Danielle Ternyila | Authors

Study Finds No Difference in Disease Recurrence Between Tamoxifen, Anastrozole in Postmenopausal Women With DCIS

December 10, 2020

An analysis of tamoxifen versus anastrozole showed no significant difference in terms of disease recurrence in postmenopausal women with locally excised ductal carcinoma in situ; however, the findings may highlight the understanding of associated toxicities.

Addition of Navitoclax Improves Spleen Volume, Symptoms in Relapsed/Refractory Myelofibrosis

December 05, 2020

Study results showed that adding navitoclax to ruxolitinib resulted in a clinically meaningful improvement in spleen volume and total symptom score in patients with myelofibrosis who no longer benefited from prior ruxolitinib therapy.